Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMNDS19)

• Drug Name: 4-Flourobenzenesulfonamide Drug Info
• Synonyms: 4-Fluorobenzenesulfonamide; 402-46-0; p-Fluorobenzenesulfonamide; 4-fluorobenzenesulphonamide; 4-fluorobenzene-1-sulfonamide; p-Fluorobenzenesulphonamide; 4-FLOUROBENZENESULFONAMIDE; EINECS 206-946-2; 4-fluoro-benzenesulfonamide; BRN 2832246; Benzenesulfonamide, p-fluoro-; Benzenesulfonamide, 4-fluoro-; PubChem2167; ACMC-1ACSJ; 4-Fuloro sulfonamide, C; 4-fluorobenzene sulfonamide; Cambridge id 5135296; AC1Q55BS; AC1L3QD2; 4-fluoranylbenzenesulfonamide; 4-fluoro benzene sulfonamide; Benzenesulfonamide,4-fluoro-; 4-11-00-00102 (Be

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Cross-matching ID:
  PubChem CID: 120231
  CAS Number: CAS 402-46-0
  TTD Drug ID: DMNDS19

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Carbonic anhydrase II (CA-II)	TTANPDJ	CAH2_HUMAN	Inhibitor	[1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule	Molecule Type	Gene Name	Liver	Colon	Kidney	Small Intestine
Carbonic anhydrase II (CA-II)	DTT	CA2	8.796	10.933	9.395	9.819

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Carbonic anhydrase II (CA-II)	DTT	CA2	7.95E-08	0.52	0.33

References

• [1] How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.